China, Aug. 24 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'An Exploratory Study of Relmaclip α Combined with Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130553

Registration Time: 2026/08/21

Type: Interventional study

Primary Sponsor: Anhui Provincial Cancer Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=338006

Published by HT Digital Content Services with permission from Health Daily Digest....